发明授权
US08119159B2 Solid oral dosage form containing an enhancer 有权
含有增强剂的固体口服剂型

Solid oral dosage form containing an enhancer
摘要:
The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to promote absorption of the bisphosphonate at the GIT cell lining. The enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms. Preferably, the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.
公开/授权文献
信息查询
0/0